{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:55:51Z","timestamp":1774608951541,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>Primary cutaneous lymphomas (PCL) often strongly differ in clinical behavior and prognosis from systemic lymphomas of the same histopathologic type. The aim of the study was to investigate the distribution of PCL subtypes, the average time from disease manifestation to diagnosis, the importance of diagnostic procedures, the occurrence of secondary malignancies and the different treatment modalities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p>Retrospective analysis of 152 patients with PCL examined at the Department of Dermatology of the University Hospital T\u00fcbingen from 2010\u20132012.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>105 patients with CTCL (69.1\u00a0%) and 47 patients with CBCL (30.9\u00a0%) were included. The average time from disease manifestation to diagnosis was four years. The most common diagnosed lymphoma was mycosis fungoides (MF) (47.4\u00a0%). First\u2010line therapies here include phototherapy only (psoralen\u2010UV\u2010A [PUVA], n\u00a0=\u00a048; UVB 311\u00a0nm, n\u00a0=\u00a07) or combination therapies primarily phototherapy with systemic retinoids (n\u00a0=\u00a018). Most frequent second\u2010line therapy was interferon (INF)\u2010\u03b1 plus PUVA (n\u00a0=\u00a015). The outcome was favorable (45.2\u00a0% remission, 28.6\u00a0% stable disease, 22.6\u00a0% progressive disease). Malignant comorbidities were observed more frequently compared to a healthy control group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The diagnosis of lymphoma often takes several years. The value of staging procedures is still low and the treatment modalities for MF in earlier stages are mainly based on phototherapy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ddg.14400","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T04:56:37Z","timestamp":1613278597000},"page":"373-381","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas"],"prefix":"10.1111","volume":"19","author":[{"given":"Alexander","family":"Scheu","sequence":"first","affiliation":[{"name":"Department of Dermatology Eberhard Karls University  Tuebingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia Maria","family":"Schnabl","sequence":"additional","affiliation":[{"name":"Department of Dermatology Eberhard Karls University  Tuebingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Patric","family":"Steiner","sequence":"additional","affiliation":[{"name":"Department of Dermatology Eberhard Karls University  Tuebingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Neuropathology Eberhard Karls University  Tuebingen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Berneburg","sequence":"additional","affiliation":[{"name":"Department of Dermatology Eberhard Karls University  Tuebingen Germany"},{"name":"Clinic and Polyclinic for Dermatology University Hospital Regensburg  Regensburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Sadegh","family":"Yazdi","sequence":"additional","affiliation":[{"name":"Department of Dermatology Eberhard Karls University  Tuebingen Germany"},{"name":"Department of Dermatology and Allergology University Hospital RWTH Aachen  Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.15.1240"},{"issue":"12","key":"e_1_2_8_4_1","first-page":"1266","article-title":"S2k Guidelines \u2013 Cutaneous Lymphomas Update 2016 \u2013 Part 1: Classification and Diagnosis (ICD10 C82 \u2010 C86)","volume":"15","author":"Dippel E","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"e_1_2_8_5_1","first-page":"112","article-title":"S2k Guidelines \u2013 Cutaneous Lymphomas Update 2016 \u2013 Part 2: Treatment and Follow\u2010up (ICD10 C82 \u2010 C86)","volume":"16","author":"Dippel E","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"e_1_2_8_6_1","first-page":"275","article-title":"Primary cutaneous diffuse large B\u2010cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences","volume":"17","author":"Felcht M","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"e_1_2_8_7_1","first-page":"1207","article-title":"Cutaneous B\u2010cell lymphomas \u2013 pathogenesis, diagnostic workup, and therapy","volume":"14","author":"Nicolay JP","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"issue":"1","key":"e_1_2_8_9_1","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-055749"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054601"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.02.027"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy133"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.01.076"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184168"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17240"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3653"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13044"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17258"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124696"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200001000-00005"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2013.2010"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-007-0127-y"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.02.039"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27627"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00614_10.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10706"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.5905"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.02.027"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25577"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31266-7"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-020-00561-w"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30379-6"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.3241"},{"issue":"3","key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ddg.13188","article-title":"Intralesional anti\u2010CD20 antibody for low\u2010grade primary cutaneous B\u2010cell lymphoma: Adverse reactions correlate with favorable clinical outcome","volume":"15","author":"Eberle FC","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-634394"},{"issue":"7","key":"e_1_2_8_37_1","first-page":"10705","article-title":"Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cell lymphoma: a systematic review and meta\u2010analysis","volume":"8","author":"Fang C","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0155-3"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70017-6"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.011"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2018.30.3.335"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.07.075"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.04.004"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e318217393f"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14400","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ddg.14400","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:29:09Z","timestamp":1693549749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.14400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1111\/ddg.14400"],"URL":"https:\/\/doi.org\/10.1111\/ddg.14400","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"2020-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}